Drug intelligence / Profile preview

Chanfuan Granules

Development stage: Unknown
Administration: Oral

Overview

Chanfuan Granules (产妇安颗粒) is a traditional Chinese medicine (TCM) preparation in granule form, primarily indicated for postpartum recovery. It is used to address conditions such as postpartum abdominal pain caused by blood stasis and persistent lochia. The formulation typically includes a combination of herbal ingredients such as Angelica sinensis, Ligusticum striatum, Carthamus tinctorius, Prunus persica, Glycyrrhiza uralensis, processed dried ginger, and Leonurus japonicus. Pharmacological studies suggest it possesses anti-inflammatory and analgesic properties, and may enhance immune function and promote lymphocyte proliferation. It is approved as a pharmaceutical drug in China under a National Medical Product Approval Number.

Brand names: 产妇安颗粒
Other names: Chanfuan

Beyond the preview

Go deeper on Chanfuan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chanfuan Granules.

Explore the full profile